Last reviewed · How we verify
TRX103
At a glance
| Generic name | TRX103 |
|---|---|
| Sponsor | Tr1X, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious Uveitis (PHASE1)
- Treatment of Moderate to Severe Refractory Crohn's Disease (PHASE1, PHASE2)
- Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TRX103 CI brief — competitive landscape report
- TRX103 updates RSS · CI watch RSS
- Tr1X, Inc. portfolio CI